Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
May 31, 2020
May 31, 2019
May 31, 2020
May 31, 2019
Income Statement [Abstract]        
Net revenue $ 1,190,404 $ 105,769 $ 1,338,984 $ 116,876
Cost of goods sold (674,178) (75,284) (856,957) (80,833)
Gross profit 516,226 30,485 482,027 36,043
OPERATING EXPENSES        
Depreciation 7,394 7,843 13,908 17,021
Amortization of patent rights 16,218 1,833 32,436 3,666
Foreign currency transaction loss (gain) 5,280 (29,254) 9,235 (15,721)
Selling, general and administrative 1,345,823 728,893 2,911,653 1,826,861
TOTAL OPERATING EXPENSES 1,374,715 709,315 2,967,232 1,831,827
LOSS FROM OPERATIONS (858,489) (678,830) (2,485,205) (1,795,784)
OTHER (EXPENSE) INCOME        
Accretion of debt discounts (257,277) (202,202) (755,401) (305,060)
Interest expense (73,562) (88,036) (233,095) (147,426)
Loss on extinguishment of debt (6,026,657)   (6,026,657)  
Warrant inducement expense (845,415)   (845,415)  
Change in fair value of derivative liabilities   250,337   645,767
LOSS BEFORE INCOME TAXES (8,061,400) (718,731) (10,345,773) (1,602,503)
Income tax provision      
NET LOSS (8,061,400) (718,731) (10,345,773) (1,602,503)
Foreign exchange translation adjustment for the period 132,524 (24,379) 95,928 (28,119)
COMPREHENSIVE LOSS $ (7,928,876) $ (743,110) $ (10,249,845) $ (1,630,622)
Net loss per share - basic and diluted (in dollars per share) $ (0.07) $ (0.01) $ (0.09) $ (0.02)
Weighted-average number of common shares outstanding during the period (in shares) 120,687,594 103,632,174 112,717,187 103,040,621